Skip to content

IDENIX PHARMACEUTICALS INC

CIK 0001093649

← back to feed
Revenue (TTM)
−$28.95M
−2,805.3% YoY Q2 Jul 2014
Net Income (TTM)
−$161.45M
+15.6% YoY Q2 Jul 2014
EPS Diluted (TTM)
−$0.35
−666.7% YoY Q2 Jul 2014
Gross Margin
104.2%
Q2 Jul 2014
Operating Margin
561.4%
Q2 Jul 2014
Net Margin
557.7%
Q2 Jul 2014
Free Cash Flow (TTM)
−$109.88M
Q2 Jul 2014
Cash
$177.61M
Q2 Jul 2014
Total Debt
—
Q2 Jul 2014
Shares Outstanding
151.5M sh
Q2 Jul 2014

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings